Cargando…
Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma
Sebaceous carcinomas (SeC) are cutaneous malignancies that, in rare cases, metastasize and prove fatal. Here we report whole-exome sequencing on 32 SeC, revealing distinct mutational classes that explain both cancer ontogeny and clinical course. A UV-damage signature predominates in 10/32 samples, w...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951856/ https://www.ncbi.nlm.nih.gov/pubmed/29760388 http://dx.doi.org/10.1038/s41467-018-04008-y |
_version_ | 1783323083131584512 |
---|---|
author | North, Jeffrey P. Golovato, Justin Vaske, Charles J. Sanborn, J. Zachary Nguyen, Andrew Wu, Wei Goode, Benjamin Stevers, Meredith McMullen, Kevin Perez White, Bethany E. Collisson, Eric A. Bloomer, Michele Solomon, David A. Benz, Stephen C. Cho, Raymond J. |
author_facet | North, Jeffrey P. Golovato, Justin Vaske, Charles J. Sanborn, J. Zachary Nguyen, Andrew Wu, Wei Goode, Benjamin Stevers, Meredith McMullen, Kevin Perez White, Bethany E. Collisson, Eric A. Bloomer, Michele Solomon, David A. Benz, Stephen C. Cho, Raymond J. |
author_sort | North, Jeffrey P. |
collection | PubMed |
description | Sebaceous carcinomas (SeC) are cutaneous malignancies that, in rare cases, metastasize and prove fatal. Here we report whole-exome sequencing on 32 SeC, revealing distinct mutational classes that explain both cancer ontogeny and clinical course. A UV-damage signature predominates in 10/32 samples, while nine show microsatellite instability (MSI) profiles. UV-damage SeC exhibited poorly differentiated, infiltrative histopathology compared to MSI signature SeC (p = 0.003), features previously associated with dissemination. Moreover, UV-damage SeC transcriptomes and anatomic distribution closely resemble those of cutaneous squamous cell carcinomas (SCC), implicating sun-exposed keratinocytes as a cell of origin. Like SCC, this UV-damage subclass harbors a high somatic mutation burden with >50 mutations per Mb, predicting immunotherapeutic response. In contrast, ocular SeC acquires far fewer mutations without a dominant signature, but show frequent truncations in the ZNF750 epidermal differentiation regulator. Our data exemplify how different mutational processes convergently drive histopathologically related but clinically distinct cancers. |
format | Online Article Text |
id | pubmed-5951856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-59518562018-05-16 Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma North, Jeffrey P. Golovato, Justin Vaske, Charles J. Sanborn, J. Zachary Nguyen, Andrew Wu, Wei Goode, Benjamin Stevers, Meredith McMullen, Kevin Perez White, Bethany E. Collisson, Eric A. Bloomer, Michele Solomon, David A. Benz, Stephen C. Cho, Raymond J. Nat Commun Article Sebaceous carcinomas (SeC) are cutaneous malignancies that, in rare cases, metastasize and prove fatal. Here we report whole-exome sequencing on 32 SeC, revealing distinct mutational classes that explain both cancer ontogeny and clinical course. A UV-damage signature predominates in 10/32 samples, while nine show microsatellite instability (MSI) profiles. UV-damage SeC exhibited poorly differentiated, infiltrative histopathology compared to MSI signature SeC (p = 0.003), features previously associated with dissemination. Moreover, UV-damage SeC transcriptomes and anatomic distribution closely resemble those of cutaneous squamous cell carcinomas (SCC), implicating sun-exposed keratinocytes as a cell of origin. Like SCC, this UV-damage subclass harbors a high somatic mutation burden with >50 mutations per Mb, predicting immunotherapeutic response. In contrast, ocular SeC acquires far fewer mutations without a dominant signature, but show frequent truncations in the ZNF750 epidermal differentiation regulator. Our data exemplify how different mutational processes convergently drive histopathologically related but clinically distinct cancers. Nature Publishing Group UK 2018-05-14 /pmc/articles/PMC5951856/ /pubmed/29760388 http://dx.doi.org/10.1038/s41467-018-04008-y Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article North, Jeffrey P. Golovato, Justin Vaske, Charles J. Sanborn, J. Zachary Nguyen, Andrew Wu, Wei Goode, Benjamin Stevers, Meredith McMullen, Kevin Perez White, Bethany E. Collisson, Eric A. Bloomer, Michele Solomon, David A. Benz, Stephen C. Cho, Raymond J. Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma |
title | Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma |
title_full | Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma |
title_fullStr | Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma |
title_full_unstemmed | Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma |
title_short | Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma |
title_sort | cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951856/ https://www.ncbi.nlm.nih.gov/pubmed/29760388 http://dx.doi.org/10.1038/s41467-018-04008-y |
work_keys_str_mv | AT northjeffreyp celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT golovatojustin celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT vaskecharlesj celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT sanbornjzachary celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT nguyenandrew celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT wuwei celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT goodebenjamin celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT steversmeredith celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT mcmullenkevin celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT perezwhitebethanye celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT collissonerica celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT bloomermichele celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT solomondavida celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT benzstephenc celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma AT choraymondj celloforiginandmutationpatterndefinethreeclinicallydistinctclassesofsebaceouscarcinoma |